Fairmount Funds Management LLC - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 131 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
Fairmount Funds Management LLC ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2024$63,231,513
+25.0%
3,204,841
+11.2%
6.89%
+29.0%
Q4 2023$50,571,696
+17.7%
2,883,221
+16.5%
5.34%
+3.3%
Q3 2023$42,983,125
+333.4%
2,474,561
+251.3%
5.17%
+269.9%
Q2 2023$9,918,783
+204.4%
704,459
+231.1%
1.40%
+1.3%
Q3 2020$3,259,000
-36.1%
212,746
+6.3%
1.38%
-39.3%
Q2 2020$5,099,000
+64.6%
200,1250.0%2.27%
+21.0%
Q1 2020$3,098,000
+69.5%
200,125
+21.1%
1.88%
+69.6%
Q4 2019$1,828,000165,3181.11%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 30,000$560,1000.52%
ADIRONDACK TRUST CO 875$16,2660.01%
CWM, LLC 451$80.00%
BARCLAYS PLC 34,839$6500.00%
OSAIC HOLDINGS, INC. 623$11,6310.00%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders